Chemotherapy for medulloblastomas and primitive neuroectodermal tumors

Journal of Neuro-Oncology

Volumn 29, Issue 1, 1996, Pages 55-68

  Cohen, Bruce H ^a   Packer, Roger J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Chemotherapy; Medulloblastoma; PNET; Primitive neuroectodermal tumors; Recurrence

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IPROPLATIN; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

BONE MARROW RESCUE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MEDULLOBLASTOMA; MULTICENTER STUDY; NEUROECTODERM TUMOR; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TUMOR RECURRENCE;

BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; HUMANS; MEDULLOBLASTOMA; MULTICENTER STUDIES; NEUROECTODERMAL TUMORS, PRIMITIVE; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION;

EID: 0029895697     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00165518     Document Type: Review

References (58)

1. Bruno LA, Rorke LB, Norris DG: Primitive neuroectodermal tumors of infancy and childhood. In: Humphrey GB et al. (eds) Pediatric Oncology, Volume 1. Boston, MA, Martinus Nijhoff Publishers, 1981, pp 265-267
2. Gaffney CC, Slone JP, Bradley NJ et al.: Primitive neuroectodermal tumours on the cerebrum (pathology and treatment). J Neurooncol 3: 23-33, 1985
3. Bailey P, Gushing H: Medulloblastoma cerebelli: A common type of mid-cerebellar glioma of childhood. Arch Neur Psychiatr 14: 192-224, 1925
4. Hart MN, Earle KM: Primitive neuroectodermal tumors of the brain in children. Cancer 32: 890-897, 1973
5. Rorke LB: The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 42: 1-15, 1983
6. Molenaar WM, Jansson D, Gould Ve et al. Immunohistology in the diagnosis of pediatric brain tumors. Pediatr Neurosci 14: 11, 1988
7. Kleihues P, Burger PC, Scheithauer BW et al. : World Health Organization international classification of tumors, histological typing of tumors of the central nervous system, Springer-Verlag, Berlin, Germany, 1993
8. Chang CH, Housepian EM, Herbert C Jr: An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 93: 1351-1359, 1969
9. Packer RJ, Sutton LN, D'Angio G et al.: Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma. Pediatr Neurosci 12: 272-282, 1986
10. Packer RJ: Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28: 823-828, 1990
11. Evans AE, Jenkin RDT, Sposto R, Ortega JA, Wilson CB, Wara W et al.: The treatment of medulloblastoma. J Neurosurg 72: 572-582, 1990
12. Cohen BH, Zeltzer PM, Boyett JM, Geyer JR, Allen JC, Finlay JL et al.: Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy. A Childrens Cancer Group randomized trial. J Clin Oncol 13: 1687-1696, 1995
13. Wald B, Siegel SE, Issacs H et al.: Cerebral primitive neuroectodermal tumor (primary cerebral neuroblastoma): CHLA exprience. In: Humphrey GB, Dehner LP, Grindey GB, Acton RT (eds) Pediatr Oncology. Boston, MA, Martinus Nijhoff, 1981, pp 229-134
14. Zeltzer P, Boyett J, Finlay J et al.: Prognostic factors for survival differ in high-risk infra- and supratentorial primitive neuroectodermal tumors. Fed Neurosurgery 19: 333, 1993
15. Paterson R, Farr RF: Cerebellar medulloblastoma: Treatment by irradiation of the whole central nervous system. Acta Radiol 39: 323-336, 1953
16. Jenkin RDT: Medulloblastoma in childhood. Radiation therapy. Can Med Assoc J 100: 51-53, 1969
17. Harisiadis L, Chang CH: Medulloblastoma in children: A correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 2: 833-841, 1977
18. Tarbeil NJ. Loeffler JS, Silver B et al.: The change in patterns of relapse in medulloblastoma. Cancer 68: 1600-1604, 1991
19. Bloom HJG: Intracranial tumors. Response and resistance to therapeutic endeavorss. Int J Radiat Oncol Biol Phys 8: 1083-1113, 1982
20. Radcliff J, Packer RJ, Atkins TE. Bunin GR, Schut L, Goldwein JW, Sutton LN: Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy. Ann Neurol 32: 551-554, 1992
21. Deutsch M, Thomas P, Boyett J, Krischer JP, Finlay J, Kun L et al.: Low-stage medulloblastoma: A Children's Cancer Study Group (CCSG) and Pediatric Oncology Group (POG) randomized study of standard vs reduced neuraxis irradiation. Proc Annu Meet Am Soc Clin Oncol 10: A363, 1991
22. Mastrangelo R, Lasorella A, Riccardi R, Colosimo C, Iavarone A, Tornesello A et al.: Carboplatin in childhood medulloblastoma/PNET: Feasibility of an in vivo sensitivity test in and 'up-front' study. Med and Fed Oncol 214: 188-196, 1995
23. Friedman HS, Schold SC: Rational approaches to the chemotherapy of medulloblastoma. Neurol Clin 3: 843-854, 1985
24. Rosen G, Ghavimi F, Nirenberg A, Mosende C, Mehta BM: High-dose methothrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children. Cancer Treat Rep 61: 781-690, 1977
25. Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55: 749-756, 1981
26. Walker RW, Allen JC: Cisplatinum in the treatment of recurrent childhood primary brain tumors. Clin Oncol 6: 62-66, 1988
27. Allen JC, Walker R, Luks E et al.: Carboplatin and recurrent childhood brain tumors. J Clin Oncol 5: 459-463, 1987
28. Lefkowitz JB, Packer RJ, Siegel KR, Sutton LN, Schut L, Evans AE: Results of treatment of children with recurrent primitive neuroectodermal tumors-medulloblastoma with lomustine, cisplatin and vincristine. Cancer 65:412-417, 1990
29. Gentet JC, Doz F, Bouffet E. Plantaz D, Roche H, Tron P et al.: Carboplatin and VP-16 in medulloblastoma: A phase II study of the French Study of Pediatric Oncology (SFOP). Med and Ped Oncol 23: 422-427, 1994
30. Pendergrass TW, Milstein JM, Geyer JR et al.: Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5: 1221-1231, 1987
31. Friedman HS, Krischer JP, Burger P. Oakes WJ, Hockenberger B, Weiner MD et al.: Treatment of children with progressive or recurrent brain tumors with Carboplatin or iproplatin: A Pediatric Oncology Group Randomized phase II study. J Clin Oncol 10: 249-256, 1992
32. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD: Carboplatin in childhood brain tumors. A Children's Cancer Study Group phase II trial. Cancer 66: 2465-2469, 1990
33. Finlay J, Garvin J, Allen J, Boyett J, Heller G, Yates A et al.: High-dose chemotherapy with autologous marrow rescue in patients with recurrent medulloblastoma/primitive neuroectodermal tumors. Proc Annu Meet Am Soc Clin Oncol 13: A493, 1994
34. van Eys J, Baram TZ, Cangir A, Bruner JM, Martinez-Prieto J: Salvage chemotherapy for tumors in children. J Peds 113: 601-606, 1988
35. Phillips PA: Antineoplastic drug resistance in brain tumors. Neurologic Clinics 9: 383-404, 1991
36. Tait DM, Thorton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26: 464-469, 1990
37. Krischer JP, Ragab AH, Kun L, Kim TH, Lauret JP, Boyett JM et al.: Nitrogen mustard vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 905-909, 1991
38. Bloom HJG, Bessell EM: Medulloblastoma in adults: A review of 47 patients treated between 1951 and 1981. Int J Radiat Oncol Biol Phys 18: 763-772, 1990
39. van Eys J, Chen T, Moore T, Cheek W, Sexauer C, Starling K: Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: A Southwest Oncology Group study. Cancer Treat Rep 65: 681-684, 1981
40. Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS et al.: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 81: 690-698, 1994
41. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan JR et al.: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433-440, 1991
42. Goldwein JW, Radcliffe J, Packer RJ, Sutton LN, Lange B, Rorke LB, D'Angio GJ: Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors. Cancer 71: 2647-2652, 1993
43. Levin VA, Rodriguez LA, Edwards MSB, Wara W, Liu HC, Fulton D et al.: Treatment of medulloblatoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg 68: 383-387, 1988
44. Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK et al.: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system. A phase II study. J Clin Oncol 8: 330-336, 1990
45. Mosijczuk AD, Nigro MA, Thomas PRM, Burger PC, Krischer JP, Morantz RA et al.: Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group Pilot Study. Cancer 72: 2755-2762, 1993
46. Kretschmar CS, Tarbell NJ, Kupsky W, Lavally BL, Loeffler JS, Wolfe L et al.: Pre-irradiation chemotherapy for infants and children with medulloblastoma: A preliminary report. J Neurosurg 71: 820-825, 1989
47. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME et al.: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. NEJM 328: 1725-1731, 1993
48. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL et al.: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Childrens Cancer Group. J Clin Oncol 12: 1607-1615, 1994
49. Finlay JL, Grovas A, Garvin J, Dunkel I, Bayer L, Pucceth D et al.: The 'Head Start' regimen for children less than six years of age newly-diagnosed with malignant brain tumors. Med Ped Oncol 25: 250, 1995
50. Olshan JS, Gubernick J, Packer RJ, D'Angio GJ, Goldwein JW, Willi SM, Moshang T: The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70: 2013-2017, 1992
51. Tomita T, McLone DG, Yasue M: Cerebral primitive neuroectodermal tumors in childhood. J Neuro-Oncol 6: 233-243, 1988
52. Ashwal S, Hinshaw DB, Bedros A: CNS primitive neuroectodermal tumors of childhood. Med Pediatr Oncol 12: 180-188, 1984
53. Zeltzer PM, Gaskill SJ, Marlin AE: Supratentorial primitive neuroectodermal tumors. In: Deutsch M (ed) Management of Childhood Brain Tumors. Boston, MA, Kluwer Academic Publishers, 1990
54. Jakacki RI, Zeltzer PM, Boyett JM, Albright AL, Allen JC, Geyer JR et al.: Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: A report of the Childrens Cancer Group. J Clin Oncol 13: 1377-1383, 1995
55. Bellani FF, Gasparini M, Lombardi F, Zucali R, Luccarelli G, Migliavacca F et al.: Medulloblastoma. Results of a sequential combined treatment. Cancer 54: 1956-1961, 1984
56. McIntosh S, Chen M, Sartain PA, Duncan C, Rishburn R, Klatskin EH et al.: Adjuvant chemotherapy for medulloblastoma. Cancer 56: 1316-1319, 1985
57. Allen JC, Walker R, Rosen G: Preirradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. J Clin Oncol 6: 649-653, 1988
58. Bloom HJG, Glees J, Bell J: The treatment and long-term prognosis of children with intracranial tumors: A study of 610 cases, 1950-1981